Hip Implant Manufacturers Target of Congressional Probe
Los Angeles, CA, December 23, 2011 – In response to growing concerns over the safety and efficacy of metal-on-metal hip implants, members of the U.S. Senate have proposed a new law which would require companies that manufacture these devices to conduct additional safety testing once they are made available to the public.
The senators who sponsored the bill are hoping that it will allow for greater tracking of the failure rates of these devices. Specifically, the legislation is designed to track those devices which are approved under the U.S. Food and Drug Administration’s 510(k) rule. This system allows for a streamlined approval process in which medical device manufacturers are only required to prove that their product is similar to one already available on the open market. The 510(k) process has been highly criticized in recent years, most notably after the recall of DePuy’s ASR XL Acetabular and ASR Hip Resurfacing Systems in 2010.
As part of their efforts to enhance consumer safety, the senators who proposed the bill also sent letters to five major manufacturers of medical devices, including Zimmer and Johnson & Johnson. The letters included a request for more information about how the safety of hip implants is monitored and how product recalls are handled when they become necessary.
In the case of Johnson & Johnson, the senators wanted to know specifically when the company became aware of problems with its ASR hip implants and how the safety issues were tracked. As of November 2011, the company faced approximately 3,500 lawsuits from plaintiffs alleging serious injury after receiving one of these devices.
If you or a loved one has experienced serious pain, swelling, infection, tissue damage or other negative side effects that you believe were caused by a metal-on-metal hip implant, you need to contact an experienced personal injury attorney to discuss your case. Prominent national law firm Nadrich & Cohen LLP is currently reviewing hip implant claims from patients in all 50 states. No-cost, no-obligation case evaluations are available by calling 1-800-722-0765 or visiting our hip injury resource center at www.DePuyHipReplacementLawyers.net.
Nadrich & Cohen LLP is a national law firm specializing in representing clients nationwide who’ve been injured by defective medical devices, harmful prescription drugs, faulty products, traffic accidents, workplace accidents and dog bites. To learn more about our firm, visit www.PersonalInjuryLawCal.com.
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Los Angeles, CA 90025
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hip Implant Manufacturers Target of Congressional Probe here
News-ID: 205333 • Views: 1945
More Releases from Nadrich & Cohen LLP
Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation. Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants. Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems. The two-day panel, which is expected
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the
More Releases for Johnson
Catheters Market | Medtronics, Inc., Johnson & Johnson, and Abbott Laboratories
Global Catheters Market: Key Trends The demand in the world catheters market is prognosticated to ride on the timely boost received through the surge in minimally invasive surgeries for operational, monitoring, and diagnostic purposes. This surge could be ascribed to the development in technology which caused the shift to minimally invasive procedures from traditional methods. In respect of the advantage of minimal complications post the procedure, less scarring, and shorter
Vision Care Market is Booming Worldwide | Essilor, Johnson & Johnson, Novartis
HTF MI released a new market study on Global Vision Care Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates
Nanomedicines Market major companies Abbott Laboratories, GE Healthcare, Johnson …
Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures. Increasing prevalence of diseases
Biotechnology Market - Development Outlook 2025 | Pfizer, Johnson & Johnson
Global Biotechnology Market: Overview The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases. The advent of stem cell technology, nanotechnology, and cloning has also propelled this market substantially and is expected to continue aiding to this market in the years to come. However, the dearth of awareness among consumers
Global Skin Toner Market 2018-2023 L’Oreal, Kose, Johnson & Johnson
Skin Toner Market Research 2018 A market study "Global Skin Toner Market" examines the performance of the Skin Toner market 2018. It encloses an in-depth Research of the Skin Toner market state and the competitive landscape globally. This report analyzes the potential of Skin Toner market in the present and the future prospects from various angles in detail. The Global Skin Toner Market 2018 report includes Skin Toner market Revenue, market Share,
Cytokines Market 2017 - AbbVie, Johnson & Johnson, GlaxoSmithKline, Sanofi
Apex Research, recently published a detailed market research study focused on the "Cytokines Market" across the global, regional and country level. The report provides 360° analysis of "Cytokines Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cytokines industry, and estimates the future trend of Cytokines market on the basis of this